(Last updated: September 2021)

Appendix B: Panel Roster and Financial Disclosures

Candidiasis

Mucocutaneous Candidiasis
Member Institution Financial Disclosure
Company Relationship
Michail Lionakis* National Institutes of Health None N/A
Michael Mansour Massachusetts General Hospital GenMark Diagnostics Scientific Advisory Board

Genetech

Thermo Fisher Scientific

Research Support (paid to institution)
Sorrento Therapeutics Equity Interest

Vericel

Pulsethera

NED Biosystems

Day Zero Diagnostics

Clear Creek Bio

Consultant
Jeniel Nett University of Wisconsin–Madison, School of Medicine and Public Health None N/A
Sanjay Revankar Wayne State University, School of Medicine Merck Consultant
Jack Sobel Wayne State University, School of Medicine None N/A

* Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting is from July 2021 through July 2022.

 

 

Download Guidelines